Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership169,012 shares
Latest Disclosed Value $ 25,824,844
Advisor Group Holdings, Inc. reports 1.37% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 169,012 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $25,816,583 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 166,724 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 1.37% during the quarter. The current value of the position is $25,209,830 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 169,012 2,288 1.37 25,825 12.32 0.0220
2026-02-17 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 166,724 -65,183 -28.11 22,993 -22.11 0.0336
2025-11-14 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 231,907 50,430 27.79 29,519 38.13 0.0413
2025-09-04 2025-06-30 13F/A-1 OVARTIS SPONSORED ADR 66987V109 181,477 79,507 77.97 21,371 87.89 0.0380
2025-08-13 2025-06-30 13F OVARTIS SPONSORED ADR 66987V109 142,580 40,610 15,015 0.0174
2025-05-12 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 101,970 -19,103 -15.78 11,375 -3.47 0.0253
2025-06-06 2024-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 121,073 10,559 9.55 11,784 -7.32 0.0264
2025-02-07 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 108,435 -2,079 11,560 0.0295
2024-11-13 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 110,514 3,083 2.87 12,714 11.14 0.0287
2024-08-13 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 107,431 16,095 17.62 11,439 29.40 0.0270
2024-05-10 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 91,336 -102,478 -52.87 8,840 -54.84 0.0197
2024-02-12 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 193,814 -53,655 -21.68 19,573 -22.31 0.0343
2023-11-13 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 247,469 91,036 58.19 25,196 59.66 0.0372
2023-08-21 2023-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 156,433 17,477 12.58 15,781 23.31 0.0283
2023-08-10 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 187,105 48,149 15,750 0.0043
2023-05-12 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 138,956 3,167 2.33 12,798 3.88 0.0241
2023-02-10 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 135,789 -3,430 -2.46 12,319 16.40 0.0249
2022-11-14 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 139,219 476 0.34 10,583 -9.82 0.0242
2022-08-10 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 138,743 8,610 6.62 11,735 -1.60 0.0259
2022-05-04 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 130,133 5,341 4.28 11,926 9.23 0.0231
2022-02-03 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 124,792 6,536 5.53 10,918 12.86 0.0207
2021-11-05 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 118,256 -4,017 -3.29 9,674 -13.31 0.0202
2021-08-02 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 122,273 2,228 1.86 11,159 8.67 0.0242
2021-05-13 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 120,045 -11,401 -8.67 10,269 -17.27 0.0247
2021-02-10 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 131,446 1,822 1.41 12,412 10.08 0.0331
2020-11-12 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 129,624 -2,116 -1.61 11,275 -2.08 0.0337
2020-08-14 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 131,740 -97,566 -42.55 11,515 -1.68 0.0386
2020-05-18 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 229,306 229,306 11,712 0.0479
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.